APA (7th ed.) Citation

L, H., KM, M., HMM, A., L, W., K, S., SC, N., . . . C, K. (2022). Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells. Frontiers in oncology, 12, 874325. https://doi.org/10.3389/fonc.2022.874325

Chicago Style (17th ed.) Citation

L, Heinemann, et al. "Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells." Frontiers in Oncology 12 (2022): 874325. https://doi.org/10.3389/fonc.2022.874325.

MLA (9th ed.) Citation

L, Heinemann, et al. "Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells." Frontiers in Oncology, vol. 12, 2022, p. 874325, https://doi.org/10.3389/fonc.2022.874325.